Status:
WITHDRAWN
Comparative Study of Techniques in Melanocyte-Keratinocyte Transplantation for the Treatment of Vitiligo
Lead Sponsor:
Henry Ford Health System
Conditions:
Vitiligo
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
PHASE3
Brief Summary
Previous studies have evaluated the transplantation of pigment cells (melanocytes)and skin cells (keratinocytes) for the treatment of vitiligo. This procedure is known as MKTP (Melanocyte Keratinocyte...
Eligibility Criteria
Inclusion
- Be at least 18 years old
- Have a diagnosis of generalized vitiligo-vitiligo affecting both sides of the body on one or more areas of the body (extremities, trunk, etc.)
- Have stable vitiligo, defined as no new lesion development (or expansion of existing lesions) in the 6 months prior to proposed procedure date
- Be able to understand the requirements of the study, the risks involved, and be able to sign the informed consent form
- Agree to follow and undergo all study-related procedures
Exclusion
- Female patients self-reported to be lactating, pregnant, or planning to become pregnant
- Patients with a history of developing vitiligo or hypertrophic scars at sites of trauma
- Patients self-reported as having HIV or Hepatitis C
- Patients self-reported as having uncontrolled Diabetes Mellitus
- The investigator feels the patient should not participate in the study for any reason
- Patients with acral vitiligo, defined as significant involvement of the fingers and/or toes
- Patients with focal or segmental vitiligo, defined as vitiligo affecting only one area of the body on only one side of the body
- Patients with vitiligo affecting greater than 30% of their body surface area
Key Trial Info
Start Date :
May 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01822379
Start Date
May 1 2010
End Date
July 1 2012
Last Update
March 10 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henry Ford Hospital Department of Dermatology
Detroit, Michigan, United States, 48202